Post by Myriad Genetics

Myriad Genetics is headed to the #ASCO26 Annual Meeting: The Place to Behold the Future of Cancer Care next month to share how our precision testing solutions support confident, guideline-driven decisions across the cancer care continuum! Join our Industry Expert Theater* featuring Dale Muzzey, PhD, for an introduction to the Precise MRD™ Test. This session will cover assay technical details and emerging clinical evidence across multiple solid tumors, including breast and colorectal cancers, and explore the role of highly sensitive molecular residual disease (MRD) detection across the care continuum. Learn more or request a dedicated meeting: https://lnkd.in/g7wJeQPA #oncology #myriadoncology #geneticinsights *Not an official event of the 2026 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation. Not CME-accredited.